Job opportunities
Call for expression of interest for National Experts on Secondment (European Medicines Agency, London)
Published: 07/05/09
The European Medicines Agency wishes to set up a permanent list of scientific candidates interested in a short-term work opportunity as National Expert on Secondment. Applications to become a National Expert on Secondment will be kept for three years. The spirit of the rules on National Experts on Secondment is to enhance and develop the relationship between European public administrations. Candidates MUST have current employment in the Public Sector (such as University, Research Institute, Public hospital or Regulatory body) of one of the member states of the European Union and a good level of English, the language in which the Agency mainly works.
General conditions: For the duration of the secondment contract, the European Medicines Agency may reimburse all or part of the gross remuneration to the current employer, pays a monthly travel allowance based on the distance to the place of deemed residence and provides a daily subsistence allowance of up to £123 per day, (please consult the 'Rules applicable to on National Experts on secondment to the EMA' for more details). The contract is not renewable and does not lead to subsequent employment at the European Medicines Agency. The contract duration is for full time employment and is generally 12 to 18 months (to be agreed with the current employer).
The European Medicines Agency is a multicultural work environment, and the working language is English.
The European Medicines Agency is located in Canary Wharf, London, UK.
Please send CV, contact details and letter of motivation in English to
Ms Frances Nuttall
Head of Human Resources
European Medicines Agency
7 Westferry Circus
Canary Wharf
London E14 4HB
United Kingdom
Positions immediately available
Expert on Secondment for Safety of Veterinary Medicines Sector
A position is immediately available in the Safety of Veterinary Medicines Sector – European Medicines Agency.
Requested qualifications:
Successful candidates are likely to have scientific training in one of the life sciences, preferably with relevance to the activities described below. A good command of English is required. Experience relevant to the particular area described below and previous administrative experience would be an advantage.
Job description:
The main area of activity will be to support the sector with referrals and arbitrations to the Committee for Medicinal Products for Veterinary Use concerning safety issues related to authorisation and use of veterinary medicinal products. Involvement may also be possible in specific projects run by the sector related to limiting the potential risk to man from the use of antimicrobials in veterinary medicine, environmental risk assessment of veterinary medicinal products and outcomes assessment related to the setting of Maximum Residue Limits.
Expert on Secondment for Pharmacovigilance and Risk Management Sector - ENCePP
One position is available in Pharmacovigilance and Risk Management to work at the core of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). This position is on a full time basis for 12 months initially. The contract is renewable and the successful candidate should ideally to start work in March or April 2010.
Requested qualifications:
Ideally candidates should have experience in the area of pharmacoepidemiology or pharmacovigilance, as well as operational experience in the management and coordination of projects or networks. A very good knowledge of English with excellent written and oral communication skills is required.
Job description
Specific responsibilities will include:
- to project manage and coordinate the implementation of ENCePP in accordance with our Road Map 2010, the Agency's and ENCePP annual work plans. The overall purpose is to contribute to the development of a functional EU intensive drug monitoring network
- to work in the ENCePP Secretariat and support the ENCePP Steering Group and the ENCePP Working Groups as well as the Agency’s ENCePP team. More specifically, working with the administrative team and to ensure effective meetings of the ENCePP community and its bodies and provide the Secretariat functions for such meetings (agenda, minutes, etc),
- to maintain contacts on an international level with a view to collaborating with similar initiatives such as US-Sentinel and DSEN (Canada),
- to establish and maintain a Pan European Inventory of European research centres and pharmacoepidemiological data sources available in the EU,
- to contribute to the development and maintenance of a registry of post-authorisation studies in ENCePP
Expert on Secondment for Safety of Veterinary Medicines Sector
A position is immediately available in the Safety of Veterinary Medicines Sector – European Medicines Agency.
Requested qualifications:
Successful candidates are likely to have scientific training in one of the life sciences, preferably with relevance to the activities described below. A good command of English is required. Experience relevant to the particular area described below and previous administrative experience would be an advantage.
Job description:
The main area of activity will be to support the sector with referrals and arbitrations to the Committee for Medicinal Products for Veterinary Use concerning safety issues related to authorisation and use of veterinary medicinal products. Involvement may also be possible in specific projects run by the sector related to limiting the potential risk to man from the use of antimicrobials in veterinary medicine, environmental risk assessment of veterinary medicinal products and outcomes assessment related to the setting of Maximum Residue Limits.
Expert on Secondment for Quality of Medicines Sector
Two positions are immediately available in the Quality of Medicines Sector of the Unit for the Pre-Authorisation of Medicines for Human Use – European Medicines Agency.
Requested qualifications:
Successful candidates are likely to have scientific training in pharmacy or other life sciences with relevance to the activities described above. Specific training and/or experience in fields such as biotechnology and emerging technologies (e.g. cells, nanotechnology) and chemical entities (e.g. bioequivalence) would be appreciated. A good command of English is required.
Job descriptions:
- Working with the Biologics Working Party on quality of biotech and biological products.
Managing procedures for centrally authorised biotech and biological medicinal products.
New technologies (e.g. gene therapy, cell therapy).
Arranging Expert Workshops and Training Sessions.
- Working with the Quality Working Party on quality of chemical products.
Managing procedures for centrally authorised new chemical and generic medicinal products.
New technologies (e.g. chemical aspects of nanotechnology).
Arranging Expert Workshops and Training Sessions
Expert on Secondment for Paediatrics
A position is available in the Scientific Advice and Orphan Drugs Sector of the Unit for the Pre-Authorisation of Medicines for Human Use - European Medicines Agency. The contract start is as early as possible. This is a full time position for 12 to 18 months, at the European Medicines Agency (London, UK).
Requested qualifications:
Medical Doctor with a qualification or significant experience in paediatric medicine or paediatric pharmacology, and/or clinical trials in children.
Job description:
To work at the European Medicines Agency on all scientific questions related to drug development in children, and other aspects of the implementation of the European Paediatric Regulation.
The Scientific Advice and Orphan Drugs Sector is a high profile sector within the European Medicines Agency, which is responsible for advising companies on the scientific aspects of pharmaceutical and biotech quality, efficacy and safety of medicinal products for human use, and supports the Scientific Advice Working Party of the Committee for Medicinal Products for Human Use, which includes experts from academia and assessors from national medicines agencies. The Sector also supports the Committee for Orphan Medicinal Products as it is in charge of orphan drug designation, which provides incentives for drugs intended for rare diseases.
The Expert on Secondment is expected to use his/her expertise in assessing paediatric development plans for medicines intended for use in children, as proposed by pharmaceutical companies or sponsors of clinical trial s, and contributing to paediatric scientific advice .
More information on the European initiative on the European Paediatric Regulation can be found here: http://www.emea.europa.eu/htms/human/peg/pegfaq.htm and the most recent text of the Paediatric Regulation (Council Common Position 2006, preceding the second EP reading): http://www.europarl.europa.eu/oeil/file.jsp?id=5210532
Expert on Secondment for Scientific Advice
A position is immediately available in the Scientific Advice and Orphan Drugs Sector of the Unit for the Pre-Authorisation of Medicines for Human Use - European Medicines Agency. The contract start is as early as possible.
Requested qualifications:
Medical Doctor with a qualification or significant experience in clinical trials and/or methodology of clinical trials, or in a medical specialty (e.g. cardiology, pneumology, internal medicine).
Job description:
To work at the European Medicines Agency on Scientific Advice requests and procedures, and all scientific questions related to drug development.
The Scientific Advice Sector is a high profile sector within the European Medicines Agency, which is responsible for advising companies on the scientific aspects of pharmaceutical and biotech quality, on preclinical development and all issues of clinical efficacy and safety of medicinal products for human use. The Sector supports the Scientific Advice Working Party of the Committee for Medicinal Products for Human Use, which includes experts from academia and assessors from national medicines agencies.
The Expert on Secondment is expected to use his/her expertise in drafting advice to pharmaceutical companies or sponsors of clinical trials for the development of medicines in various therapeutic areas.
Expert on Secondment for Safety & Efficacy
Two position are available in the Safety & Efficacy Sector of the Unit for the Pre-Authorisation of Medicines for Human Use - European Medicines Agency.
Requested qualifications:
Medical Doctors with a qualification or significant experience in oncology, central nervous system, endocrinology/diabetes or cardiovascular system are preferable, although good background and training in internal medicine is valuable.
Job description:
To work at the European Medicines Agency on Safety & Efficacy of Medicines requests and procedures, and all scientific questions related to the concerned therapeutic area.
The Safety & Efficacy is a high profile sector within the European Medicines Agency, which is responsible for the safety and efficacy aspects of the evaluation process for centralised marketing authorisation applications from pre-submission stage right through assessment, adoption of the final scientific opinion by the Committee for Medicinal Products for Human Use (CHMP) and publication of the European Public Assessment Report (EPAR), as well as for arbitrations and referrals, emerging therapies and the secretariats of CHMP Working Parties and Scientific Advisory Groups in the fields of Diabetes/Endocrinology, Anti-infectives, Diagnostics, HIV/Viral Diseases, Central nervous System and Oncology.
Expert on Secondment for Inspections Sector
Requested qualifications:
Appropriate scientific qualification and significant experience in the GxP area
Job description:
To work at the European Medicines Agency on GxP related requests and procedures
The Sector is responsible for co-ordinating inspections requested in connection with the assessment of marketing authorisation applications and/or the assessment of matters referred to by the Scientific Committees in accordance with Community legislation. These inspections may cover GCP, GLP, GMP, Pharmacovigilance (PhV) or they may be performed in the context of Vaccine Antigen Master File (VAMF) or Plasma Master File (PMF) certification. The Sector organises and chairs regular meetings of GCP and GMP inspectors where harmonisation of inspection related procedures and guidance documents are developed and it provides secretarial support to the joint CHMP/CVMP Quality Working Party. Communication and action by Member States in response to Quality Defects relating to centrally authorised medicines are also coordinated by the Inspections sector. More information on the sectors activities is available from the European Medicines Agency's website under Inspections.

RSS feed